Stonnington Group’s United Therapeutics UTHR Stock Holding History

Stonnington Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,200	Closed	-$288K	–	224
2022 Q2	$288K	Buy	+1,200	New	+$244K	0.08%	182
2021 Q2	–	Sell	-3,900	Closed	-$762K	–	286
2021 Q1	$762K	Buy	+3,900	New	+$650K	0.18%	131

Other funds holding UTHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Stonnington Group's UTHR Position: Q3 2022 in Review

Stonnington Group sold out of United Therapeutics (UTHR) in Q3 2022, closing a stake of 1,200 shares — an estimated $288K sold.

Stonnington Group first reported a position in UTHR in Q1 2021 and held it in 2 quarters. The position peaked at $762K in Q1 2021. 459 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

Stonnington Group reported no remaining United Therapeutics position as of Q3 2022 after selling out during the quarter.
Stonnington Group sold 1,200 United Therapeutics shares in Q3 2022, an estimated $288K.
Stonnington Group first reported a position in United Therapeutics in Q1 2021 and held it in 2 quarters.
Stonnington Group's United Therapeutics position peaked at $762K in Q1 2021.
459 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on Stonnington Group's 13F filing for Q3 2022, filed 20 Oct 2022.